{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:06:23Z","timestamp":1790867183613,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the National Major and Technological Special Project for infectious disease during the Twelfth Five-year Plan Period","award":["2013ZX10005004"],"award-info":[{"award-number":["2013ZX10005004"]}]},{"name":"China Tuberculosis Clinical Trial Consortium(CTCTC) research funding","award":["2017KYJJ008"],"award-info":[{"award-number":["2017KYJJ008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3169-7","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T08:08:10Z","timestamp":1528358890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mortality and associated factors of patients with extensive drug-resistant tuberculosis: an emerging public health crisis in China"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6816-4787","authenticated-orcid":false,"given":"Chengli","family":"Bei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjiao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangruan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"key":"3169_CR1","unstructured":"World Health Organization.\u00a0Global tuberculosis report 2017. WHO\/HTM\/TB\/2017.23.\u00a0Geneva:\u00a0World Health Organization. 2017. p. 21\u201363."},{"issue":"9","key":"3169_CR2","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3201\/eid2209.160084","volume":"22","author":"CL Kvasnovsky","year":"2016","unstructured":"Kvasnovsky CL, Peter CJ, Van dWML. Treatment outcomes for patients with extensively drug-resistant tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa. Emerg Infect Dis. 2016;22(9):1529\u201336.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"3169_CR3","doi-asserted-by":"publisher","first-page":"e19399","DOI":"10.1371\/journal.pone.0019399","volume":"6","author":"CH Liu","year":"2012","unstructured":"Liu CH, Li L, Chen Z, et al. Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience. PLoS One. 2012;6(4):e19399.","journal-title":"PLoS One"},{"issue":"1","key":"3169_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1183\/09031936.00134712","volume":"42","author":"D Falzon","year":"2013","unstructured":"Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J. 2013;42(1):156\u201368.","journal-title":"Eur Respir J"},{"issue":"10","key":"3169_CR5","first-page":"800","volume":"37","author":"L Fan","year":"2014","unstructured":"Fan L, Sha W. Long - term prognosis of extensively drug-resistant TB (XDR-TB) in South Africa: a cohort study. Chin J Tuberc Res Dis. 2014;37(10):800.","journal-title":"Chin J Tuberc Res Dis"},{"issue":"9924","key":"3169_CR6","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/S0140-6736(13)62675-6","volume":"383","author":"E Pietersen","year":"2014","unstructured":"Pietersen E, Ignatius E, Streicher EM, et al. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study.[J]. Lancet. 2014;383(9924):1230\u20139.","journal-title":"Lancet"},{"issue":"9547","key":"3169_CR7","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","volume":"368","author":"NR Gandhi","year":"2006","unstructured":"Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368(9547):1575\u201380.","journal-title":"Lancet"},{"issue":"Suppl 1(2)","key":"3169_CR8","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1086\/518665","volume":"196","author":"CD Wells","year":"2007","unstructured":"Wells CD, Cegielski JP, Nelson LJ, et al. HIV infection and multidrug-resistant tuberculosis\u2014the perfect storm. J Infect Dis. 2007;196(Suppl 1(2)):S86\u2013107.","journal-title":"J Infect Dis"},{"issue":"6","key":"3169_CR9","first-page":"2171","volume":"35","author":"Organization W H","year":"2010","unstructured":"Organization W H. Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response. World Health Organization. 2010;35(6):2171\u20138.","journal-title":"World Health Organization"},{"issue":"23","key":"3169_CR10","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","volume":"366","author":"MA Espinal","year":"2012","unstructured":"Espinal MA, Laserson K, Camacho M. National Survey of drug-resistant tuberculosis in China. New Engl J Med. 2012;366(23):2161\u201370.","journal-title":"New Engl J Med"},{"issue":"12","key":"3169_CR11","doi-asserted-by":"publisher","first-page":"e82943","DOI":"10.1371\/journal.pone.0082943","volume":"8","author":"S Tang","year":"2013","unstructured":"Tang S, Tan S, Yao L, et al. Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation. PLoS One. 2013;8(12):e82943.","journal-title":"PLoS One"},{"key":"3169_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3109\/00365548.2010.548080","volume":"43","author":"SJ Tang","year":"2011","unstructured":"Tang SJ, Zhang Q, Xiao HP. Etal. Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in shanghai, China: clinical characteristics and treatment outcomes. Scand J Infect Dis. 2011;43:280\u20135.","journal-title":"Scand J Infect Dis"},{"key":"3169_CR13","unstructured":"Organization WH. Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. World Health Organization. 2014;14(6):672\u201382."},{"issue":"5","key":"3169_CR14","first-page":"421","volume":"37","author":"China Anti - tuberculosis Association","year":"2015","unstructured":"China Anti - tuberculosis Association. Guidelines for Chemotherapy for Drug - Resistant Tuberculosis (2015). Chin J Antituberc. 2015;37(5):421\u201369.","journal-title":"Chin J Antituberc"},{"issue":"3","key":"3169_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1183\/09031936.00073611","volume":"38","author":"D Falzon","year":"2011","unstructured":"Falzon D, Jaramillo E, Sch\u00fcnemann H. The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosis. Eur Respir J. 2011;38(3):516\u201328.","journal-title":"Eur Respir J"},{"key":"3169_CR16","unstructured":"Organization WH. Management of MDR-TB: a field guide: a companion document to guidelines for Programmatic Management of Drug-Resistant Tuberculosis: Integrated Management of Adolescent and Adult Illness (IMAI). Pearson Schweiz Ag. 2009;63(3):307\u201319."},{"issue":"3","key":"3169_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJMoa1604544","volume":"376","author":"NS Shah","year":"2017","unstructured":"Shah NS, Auld SC, Brust JC, et al. Transmission of extensively drug-resistant tuberculosis in South Africa. N Engl J Med. 2017;376(3):243\u201353.","journal-title":"N Engl J Med"},{"issue":"3","key":"3169_CR18","doi-asserted-by":"publisher","first-page":"e31786","DOI":"10.1371\/journal.pone.0031786","volume":"7","author":"SV Shenoi","year":"2012","unstructured":"Shenoi SV, Brooks RP, Barbour R, et al. Survival from XDR-TB is associated with modifiable clinical characteristics in rural South Africa. PLoS One. 2012;7(3):e31786.","journal-title":"PLoS One"},{"issue":"1","key":"3169_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1164\/rccm.200911-1656OC","volume":"182","author":"DH Kim","year":"2010","unstructured":"Kim DH, Kim HJ, Park SK, et al. Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2010;182(1):113\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3169_CR20","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1183\/09031936.00114214","volume":"45","author":"CC Leung","year":"2014","unstructured":"Leung CC, Yew WW, Chan CK, et al. Smoking adversely affects treatment response, outcome and relapse in tuberculosis. Eur Respir J. 2014;45(3):738\u201345.","journal-title":"Eur Respir J"},{"issue":"2","key":"3169_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4103\/0970-0218.51215","volume":"34","author":"V Sharma","year":"2009","unstructured":"Sharma V, Aggarwal S. XDR tuberculosis: a looming threat. Indian J Community Med. 2009;34(2):166.","journal-title":"Indian J Community Med"},{"issue":"1","key":"3169_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5588\/ijtld.10.0791","volume":"16","author":"JE Farley","year":"2012","unstructured":"Farley JE, Tudor C, Mphahlele M, et al. A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa [J]. Int J Tuberc Lung Dis. 2012;16(1):82\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"3169_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5588\/pha.12.0098","volume":"3","author":"C Tudor","year":"2013","unstructured":"Tudor C, Walt MVD, Hill MN, et al. Occupational health policies and practices related to tuberculosis in health care workers in KwaZulu-Natal, South Africa. Public Health Action. 2013;3(2):141\u20135.","journal-title":"Public Health Action"},{"issue":"2","key":"3169_CR24","doi-asserted-by":"publisher","first-page":"e4370","DOI":"10.1371\/journal.pone.0004370","volume":"4","author":"Z Ming","year":"2009","unstructured":"Ming Z, Xia L, Peng X, et al. Transmission of MDR and XDR tuberculosis in shanghai, China. PLoS One. 2009;4(2):e4370.","journal-title":"PLoS One"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3169-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3169-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3169-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T19:04:44Z","timestamp":1559847884000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3169-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3169"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3169-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"11 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethical Review Committee of responsible units (Changsha Central Hospital) and we had received ethics committee approval for verbal consent. We obtained verbal informed consent from all subjects on the phone, if the patient died when we tracked, the verbal consent was received from the legal representative or next of kin of the deceased patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"261"}}